Several investigators reported that increasing RBM5 levels via injection of vector plasmids in immunocompromised nude mice inoculated with A549 or BEAS-2B cancer cells inhibited tumor growth (Oh et al., 2006; Shao et al., 2012, 2013; Lv et al., 2016). Here, RBM5 is linked to neoplasm.